Skip to content
Governance Register

← US public companies

Tscan Therapeutics, Inc.

SEC CIK 1783328 · TCRX · last insider filing 2026-05-22

Directors (from insider filings)

NameCapacity as filedFilings
Baker Julian Director filed 2021–2026
Baker Felix Director filed 2021–2026
Baker Bros. Advisors LP Director filed 2021–2026
Baker Brothers Life Sciences LP Director filed 2021–2026
667, L.P. Director filed 2021–2026
Baker Bros. Advisors (GP) LLC Director filed 2021–2026
Dorton Katina Director filed 2021–2026
Nicholson Garry A Director filed 2024–2026
Klencke Barbara Director filed 2023–2026
Gruia Gabriela Director filed 2021–2026
Woods Keith Director filed 2023–2026
Macbeath Gavin Director · See Remarks filed 2021–2026
Barberich Timothy J Director filed 2021–2023
Southwell David P Director · Chief Executive Officer filed 2021–2023
Harel Ittai Director filed 2021–2022
Westphal Christoph H Director filed 2021–2021
Biggar Stephen R Director filed 2021–2021

Officers (from insider filings)

NameTitle as filedFilings
Amello Jason Chief Financial Officer filed 2024–2026
Zdraveski Zoran See Remarks filed 2021–2026
Dworak Leiden See Remarks filed 2023–2026
Louis Chrystal Chief Medical Officer filed 2024–2026
Silver Brian M. Chief Financial Officer filed 2021–2023
Barton Debora Chief Medical Officer filed 2022–2023
Desmarais William Chief Business Officer filed 2021–2022

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.